FDA Approves Oral Daprodustat to Treat Anemia in Dialysis
The FDA approval of daprodustat is based on results from the ASCEND-D trial comparing daprodustat with ESAs.
Diagnosis & Disease Information
Anemia Prevalence, Burden Characterized
In both men and women, the prevalence of severe anemia increased as kidney function decreased.
What Do We Know About Cancer Risk in Patients With Anemia?
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
HIF-PHIs and ESAs Have Comparable Adverse Effects
Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.
Post-Transplant Anemia Tied With Adverse Kidney, Cardiovascular Outcomes
According to investigators, it is crucial to find the underlying causes of post-transplant anemia and to treat all reversible causes.
Intravenous vs Oral Iron Does Not Increase CKD Risk
Investigators compared the therapies in a large national cohort of patients with normal kidney function.
Heart Failure Linked to Iron Deficiency in Older Adults
Recent study included 980 individuals older than 65 years who participated in the Cardiovascular Health Study.
Trial Explores Iron Dose to Maintain Hemoglobin, Minimize ESAs in Hemodialysis
Currently, there is no standard regimen for maintenance iron supplementation in patients receiving hemodialysis.
Iron Deficiency Without Anemia Common in Peritoneal Dialysis Population
Iron deficiency associates with adverse outcomes in patients on peritoneal dialysis, regardless of anemia status.
Paricalcitol Independently Increases Hemoglobin Levels
Paricalcitol Independently Increases Hemoglobin Levels
- Loading...
Loading...
Next post in Kidney Week 2022
Loading... 
Loading...